English
|
Español
English
|
Español
Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Patient Daily
| Dec 28, 2025
Insmed ends Brinsupri program after mid-stage trial fails in sinusitis
Patient Daily
| Dec 28, 2025
FDA partially halts Merck and Daiichi Sankyo’s lung cancer drug trial after patient deaths
Patient Daily
| Dec 28, 2025
Takeda reports positive phase III results for AI-designed plaque psoriasis drug
Patient Daily
| Dec 28, 2025
BioMarin acquires Amicus Therapeutics for $4.8 billion to expand rare disease treatments
Patient Daily
| Dec 28, 2025
Cytokinetics awaits FDA decision on aficamten for hypertrophic cardiomyopathy
Patient Daily
| Dec 28, 2025
Kyowa Kirin may see higher demand after newborn screening list expands
Patient Daily
| Dec 28, 2025
Researchers compile global catalog of stem cell lines for clinical use
Patient Daily
| Dec 28, 2025
Chitose Laboratory and Fujifilm Biosciences partner to enhance global biopharmaceutical manufacturing
Trending
+
Regulatory
Patient Daily
| Mar 5, 2026
TPA Director: RFK Jr.'s 'latest ideological crusade would be great for trial lawyers, but terrible for millions of patients'
+
Pharmaceuticals
Patient Daily
| Mar 4, 2026
Gene therapies for sickle cell disease face slow uptake despite early promise
+
Pharmaceuticals
Patient Daily
| Mar 7, 2026
FDA prepares decisions on key drugs from BMS, GSK, Aldeyra and others
+
Pharmaceuticals
Patient Daily
| Mar 9, 2026
Rep. Marshall on 340B expansion: 'If 340B is to continue growing, lawmakers should ensure it truly benefits the underserved'
« First
«
…
58
59
60
61
62
63
64
…
»
Last »